Skip to content

Clinical trials

Rhabdomyosarcoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Country / region: France Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20081
20111
20121
20132
20141
20151
20183
20202
20211
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting3
Active, not recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Centre Oscar Lambret2
Eli Lilly and Company2
Gustave Roussy, Cancer Campus, Grand Paris2
Novartis Pharmaceuticals2
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Celgene1
Eisai Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma23
Neuroblastoma8
Sarcoma8
Sarcoma, Ewing7
Fibrosarcoma6
Leiomyosarcoma6
Sarcoma, Synovial6
Hemangiosarcoma5
Histiocytoma, Malignant Fibrous5
Liposarcoma5

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.